Triple-negative breast cancer (TNBC) is a hypotype of breast cancer that is immunohistochemically based on the negative expression of the hormone receptors estrogen receptor (ER) and progesterone receptor (PR) and on the negative amplification of HER2 amplification[1]. This evidence concerns the gene PGR and breast carcinoma.